Ondansetron Hydrochloride is Used for managing symptoms of nausea and vomiting. It was first introduced by Sandoz Inc in its drug Zofran on Jan 4, 1991. Other drugs containing Ondansetron Hydrochloride are Zofran Preservative Free, Ondansetron Hydrochloride And Sodium Chloride In Plastic Container, Zofran And Dextrose In Plastic Container. 42 different companies have introduced drugs containing Ondansetron Hydrochloride.

Ondansetron Hydrochloride Patents

Given below is the list of patents protecting Ondansetron Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Zofran	US5854270 (Pediatric)	Oral compositions containing ondansetron	May 20, 2016 (Expired)	Sandoz
Zofran	US5854270	Oral compositions containing ondansetron	Nov 20, 2015 (Expired)	Sandoz

Add above patents to watchlist

Ondansetron Hydrochloride's Family Patents

Full family tree

Ondansetron Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Ondansetron Hydrochloride. The first generic version for Ondansetron Hydrochloride was by Teva Pharmaceuticals Usa and was approved on Nov 22, 2006. And the latest generic version is by Rising Pharma Holding Inc and was approved on Jul 31, 2017.

Given below is the list of companies who have filed for Ondansetron Hydrochloride generic, along with the locations of their manufacturing plants worldwide.